SEER*Rx - Interactive Antineoplastic Drugs Database
Version 1.5.0 released September 27, 2010
A review of drug classifications in SEER*RX is currently underway. The clinical oncology community have identified drugs they feel should be coded as immunotherapy/BRM and not chemotherapy. Please continue to code these agents as instructed in SEER*Rx until further notice from SEER.
SEER*Rx was developed as a one-step lookup for coding oncology drug and regimen treatment categories in cancer registries. The program is free and can be downloaded from this site. The databases are scheduled to be updated annually.
The information in this database is effective for cancer diagnoses made on January 1, 2005 and after. Review and recoding of drugs from previous years is not required or recommended.
Release Notes
The SEER*Rx Interactive Drug Database was updated on September 27, 2010. Version 1.5.0 includes 5 new regimens, 3 drugs recently approved by the FDA, and 26 new drugs. All of the newly added drugs are currently in clinical trials (Phase I, Phase II, or Phase III) and have not received final FDA approval as accepted treatment for cancer. Three drugs currently in the database have been updated to include brand names. Two drugs have changed categories: Thalidomide and Lenalidomide have both changed categories from chemotherapy to immunotherapy.
Download SEER*Rx Version 1.5.0
Download the installation program for SEER*Rx 1.5.0 [srx_setup_1_5_0.exe].
All revisions made for the current release of the software are listed in ReadMe.txt.
Sign Up for E-mail Updates
If you would like to receive notification via e-mail when new releases of the program become available, please sign up using the form below. Your information will only be used to send you future notices about the SEER*Rx program.
For More Information
For questions about missing or new drugs or regimens, or problems downloading the program, please use the Ask a SEER Registrar form.
For information about state-of-the-art drugs and regimens by primary site and stage, visit
the National Cancer Institute's Physician
Web site.
For more information about how various types of drugs work against cancer, visit
the SEER Training Web site.
